Transcript Title Page - Ennect Mail

Pneumonia in the
Critical Care Setting
Laura Loftis, M.D., M.S.
Associate Professor of Pediatrics
and Medical Ethics
Baylor College of Medicine
Objectives
1. To review diagnostic criteria for pneumonia
2. To examine treatment algorithms for pneumonia
3. Upon completion, the learner will be able to
identify controversies surrounding identification of
ventilator associated pneumonia
Page 1
xxx00.#####.ppt 7/16/2015 6:30:42 PM
Categories of pneumonia
1. Community acquired pneumonia
2. Pneumonia in special populations
‐ immunocompromised
‐ cystic fibrosis
‐ chronically ventilator dependent
3. Ventilator associated pneumonia (VAP)
Page 2
xxx00.#####.ppt 7/16/2015 6:30:44 PM
Categories of pneumonia
1. Community acquired pneumonia
2. Pneumonia in special populations
‐ immunocompromised
‐ cystic fibrosis
‐ chronically ventilator dependent
3. Ventilator associated pneumonia (VAP)
Page 3
xxx00.#####.ppt 7/16/2015 6:30:44 PM
Guideline Eligibility Criteria:
• Age ≥ 60 days to 17 years
• Healthy children without
underlying conditions
• Clinical findings of CAP
Guideline Exclusion Criteria:
• Aspiration
• Recent hospitalization (< 7 days
before the onset of illness)
Evidence-Based Outcomes Center Team:
Quinn Franklin, MS, CCLS, Research Specialist
Jennifer Nichols, MPH, Research Specialist
Charles Macias, MD, MPH, Director
Page 4
xxx00.#####.ppt 7/16/2015 6:30:45 PM
Page 5
xxx00.#####.ppt 7/16/2015 6:30:45 PM
Clinical Indicators
• May be subtle
• Fever
‐ Young infants may have afebrile pneumonia related to Chlamydia trachomatis
‐ may be the only sign of occult pneumonia in highly febrile young children
• Tachypnea
‐ absence of tachypnea - single most valuable sign for excluding pneumonia
• Respiratory distress
‐ Retractions, hypoxemia (< 90% sats on RA), irritability, nasal flaring
‐ Grunting, when present, is a sign of severe disease and impending respiratory failure
• Cough
‐ may be minimal if primarily an alveolar process
Ann Emerg Med. 1999;33(2):166; JAMA 1998;279(4):308
Page 6
xxx00.#####.ppt 7/16/2015 6:30:46 PM
Clinical Indicators - Lung exam
• Crackles or rales
• Diminished breath sounds
• Wheezes
• more common in atypical or viral
• Pleural effusion - chest pain with splinting, dullness to percussion,
distant breath sounds, pleural friction rub
Page 7
xxx00.#####.ppt 7/16/2015 6:30:46 PM
Academic Emergency Medicine, 1996: 3(5), 396
Page 8
xxx00.#####.ppt 7/16/2015 6:30:46 PM
Radiographic patterns
• Segmental consolidation - reasonably specific for bacterial pneumonia but lacks
sensitivity
‐ not always easy to distinguish from segmental collapse (atelectasis), which
is apparent in about 25 percent of children with bronchiolitis
• In a study of 254 children with radiographically defined pneumonia, the etiology
was determined in 215
‐ The sensitivity and specificity of alveolar infiltrate for bacterial pneumonia
were 72 and 51 percent, respectively
‐ the sensitivity and specificity of interstitial infiltrates for viral pneumonia
were 49 and 72 percent, respectively
Acta Paediatr. 1993;82(4):360; Pediatr Radiol. 1974;2(3):155.; J Paediatr Child Health.
Page 9 1981;36(6):469
1990;26(4):209; Pediatrics 1998;102(6):1369; Thorax. 2002;57(5):438; Thorax.
xxx00.#####.ppt 7/16/2015 6:30:47 PM
Alveolar – note airbronchograms
Interstitial
Page 10
xxx00.#####.ppt 7/16/2015 6:30:47 PM
Atelectasis
Lobar consolidation
Page 11
xxx00.#####.ppt 7/16/2015 6:30:48 PM
Pleural effusions
Page 12
xxx00.#####.ppt 7/16/2015 6:30:48 PM
RADIOLOGIC EVALUATION
• Not necessary to confirm the diagnosis of suspected CAP
‐ in children with mild, uncomplicated lower respiratory tract infection
who are well enough to be treated as outpatients
‐ Radiographic findings are poor indicators of the etiologic diagnosis
‐ Radiographic findings may lag behind the clinical findings
• For hospitalized children
‐ to assess for the presence of effusions or other complications
Page 13
xxx00.#####.ppt 7/16/2015 6:30:49 PM
Admission Criteria:
• Unable to tolerate oral fluids and medications; severely dehydrated
• Moderate or severe respiratory distress
• Failed outpatient antibiotic treatment
• Altered mental status
• Oxygen saturation consistently < 90%
• Unsafe to send home / poor follow-up
Page 14
xxx00.#####.ppt 7/16/2015 6:30:49 PM
Page 15
xxx00.#####.ppt 7/16/2015 6:30:49 PM
CAP Pathogens
• S pneumoniae
‐ Most common bacteria in all age groups
‐ less commonly S aureus or group A strep
• "Atypical" bacterial pneumonia
‐ Mycoplasma pneumoniae or Chlamydophila (formerly Chlamydia)
pneumoniae
‐ Preschool aged children had as many episodes of atypical bacterial LRIs as
older children.
• Afebrile pneumonia of infancy
‐ generally seen between two weeks and four months of life.
‐ classically caused by C. trachomatis,
Clinical Infectious Diseases 2011: 53(7), e25-e76
Page 16
xxx00.#####.ppt 7/16/2015 6:30:49 PM
Pediatrics, 2004:113(4), 701-707.
Page 17
xxx00.#####.ppt 7/16/2015 6:30:50 PM
Page 18
xxx00.#####.ppt 7/16/2015 6:30:50 PM
Page 19
xxx00.#####.ppt 7/16/2015 6:30:50 PM
Page 20
xxx00.#####.ppt 7/16/2015 6:30:50 PM
Pleural Effusion
• small, simple pleural effusions
‐ampicillin to cover S. pneumoniae.
• ill-appearing children or those with clinical deterioration
‐vancomycin and cefotaxime.
• complicated pleural effusion
‐Chest thoracostomy tube (with or without fibrinolytics) or
VATS
Page 21
xxx00.#####.ppt 7/16/2015 6:30:51 PM
Categories of pneumonia
1. Community acquired pneumonia
2. Pneumonia in special populations
‐ immunocompromised
‐ cystic fibrosis
‐ chronically ventilator dependent
3. Ventilator associated pneumonia (VAP)
Page 22
xxx00.#####.ppt 7/16/2015 6:30:51 PM
Immunocompromised pt
• humoral immune deficiencies with accompanying diminished opsonizing capacity
‐ functional asplenia, hematopoietic malignancy, transplantation, or immunoglobulin
deficiency
‐ encapsulated bacteria Streptococcus pneumoniae
• decreased cell-mediated immunity or macrophage function
‐ in patients receiving T-lymphocyte depleting therapies for rheumatologic diseases or
inflammatory bowel disease.
‐ intracellular organisms (eg, Mycobacteria, Legionella, Nocardia, Strongyloides)
‐ infection due to yeasts (eg, Histoplasma, Cryptococcus) or molds (eg, Aspergillus)
• neutrophil dysfunction* / neutropenia / receiving glucocorticoids and/or T-cell suppression**
‐ chronic granulomatous disease*
‐ organ transplant recipients who require long-term immune suppression **
‐ Nocardia and nontuberculous mycobacteria
Page 23
xxx00.#####.ppt 7/16/2015 6:30:51 PM
Immunocompromised pt
• Sequential infection
‐
Ex: viral infection preceding bacterial or fungal infection
• Multiple simultaneous infections
‐
Ex: dual infection with Pneumocystis jirovecii (formerly P. carinii)
and cytomegalovirus
• Disseminated disease (CNS, bones, abdomen)
‐
Ex: Aspergillus species, mycobacterial, or Nocardia infections
• Superimposition of another process (lung injury or drug toxicity)
N Engl J Med. 1998;338(24):1741 ; http://www.uptodate.com/contents/pulmonary-infections-in-immunocompromisedPage 24
patients?source=search_result&search=pneumonia+in+immunocompromised&selectedTitle=2%7E150
xxx00.#####.ppt 7/16/2015 6:30:53 PM
So…
• Vanc (at meningitic doses), cefotaxime, zosyn …to start
• ID consult
•Early imaging (CT / MRI) and specific microbiologic diagnoses are
essential
•Invasive procedures (biopsies and bronchoscopy) are often necessary
•advanced diagnostic testing including immunohistology and quantitative
molecular assays
•Reduction of immune suppression may be as important as antimicrobial
therapy in the ultimate success of treatment
N Engl J Med. 1998;338(24):1741 ; http://www.uptodate.com/contents/pulmonary-infections-in-immunocompromisedPage 25
patients?source=search_result&search=pneumonia+in+immunocompromised&selectedTitle=2%7E150
xxx00.#####.ppt 7/16/2015 6:30:53 PM
Categories of pneumonia
1. Community acquired pneumonia
2. Pneumonia in special populations
‐ immunocompromised
‐ cystic fibrosis
‐ chronically ventilator dependent
3. Ventilator associated pneumonia (VAP)
Page 26
xxx00.#####.ppt 7/16/2015 6:30:54 PM
Simon RH. Cystic fibrosis: Antibiotic therapy for lung disease. UpToDate
Page 27
http://www.uptodate.com/contents/cystic-fibrosis-antibiotic-therapy-for-lungdisease?source=search_result&search=cystic+fibrosis+and+pneumonia&selectedTitle=1%7E150
xxx00.#####.ppt 7/16/2015 6:30:55 PM
Cystic Fibrosis
• current culture recommendations
‐perform cultures every three months
•although the value of antibiotic susceptibility testing based
on conventional in vitro cultures has been questioned
‐the correlation between test results and clinical response is
poor
Am J Infect Control. 2003;31(3 Suppl):S1.; J Pediatr. 2009;155(6 Suppl):S73.
Page 28
xxx00.#####.ppt 7/16/2015 6:30:55 PM
Cystic Fibrosis
The persistence of bacteria despite aggressive treatment is thought to be due to:
• Poor penetration of antibiotics into purulent airway secretions
• Native or acquired antibiotic resistance
• CF-related defects in mucosal defenses
• Biofilms produced by the bacteria that may render antibiotics ineffective or
interfere with host defenses
Simon RH. Cystic fibrosis: Antibiotic therapy for lung disease. UpToDate
Page 29
http://www.uptodate.com/contents/cystic-fibrosis-antibiotic-therapy-for-lungdisease?source=search_result&search=cystic+fibrosis+and+pneumonia&selectedTitle=1%7E150
xxx00.#####.ppt 7/16/2015 6:30:56 PM
Clinical indicators to treat?
• Increased cough
• Increased sputum production or chest congestion
• Decreased exercise tolerance or increased dyspnea with exertion
• Increased fatigue
• Decreased appetite
• Increased respiratory rate or dyspnea at rest
• Change in sputum appearance
• Fever (present in a minority of patients)
• Absenteeism from school or work
• Increased nasal congestion or drainage
J Pediatr. 2001;139(3):359.
Page 30
xxx00.#####.ppt 7/16/2015 6:30:56 PM
Treatment considerations
• Pseudomonas aeruginosa
‐ Chronic infection - an independent risk factor for accelerated loss of
pulmonary function and decreased survival
‐ Conversion of P. aeruginosa to the mucoid phenotype worsens prognosis
• Burkholderia cepacia complex
‐ Chronic infection - associated with an accelerated decline in pulmonary
function and shortened survival in CF
‐ Lung transplantation is associated with recurrent and often severe infection,
‐ Lung transplantation associated with poor outcomes, particularly for those
carrying B. cenocepacia
‐ is considered to be a contraindication to transplantation in many centers
Pediatr Pulmonol. 2001;32(5):356; Pediatr Pulmonol. 2002;34(2):91; Paediatr Respir
Page 31
Rev. 2002;3(3):230; J Clin Microbiol. 2004;42(12):5537; Am J Respir
Crit Care Med.
2006;173(4):421
xxx00.#####.ppt 7/16/2015 6:30:57 PM
Treatment considerations
•treat any S. aureus
•treat Achromobacter xylosoxidans
‐ Some isolates can be particularly inflammatory and are associated
with rates of FEV1 deterioration
•uncertainty regarding the importance of treating Stenotrophomonas
maltophilia (S. maltophilia)
‐ merely a marker of more severe lung disease or a cause of it?
•Aspergillus species are generally not treated
‐ appear to be an unlikely cause of pulmonary exacerbations
Simon RH. Cystic fibrosis: Antibiotic therapy for lung disease. UpToDate
Page 32
http://www.uptodate.com/contents/cystic-fibrosis-antibiotic-therapy-for-lungdisease?source=search_result&search=cystic+fibrosis+and+pneumonia&selectedTitle=1%7E150
xxx00.#####.ppt 7/16/2015 6:30:57 PM
Treatment considerations
• When in vitro testing can identify no antibiotic to which a bacterium is
susceptible, select a combination of antibiotics that would otherwise be
chosen empirically for that pathogen.
•generally avoid using two beta lactam antibiotics simultaneously
‐ based upon in vitro studies showing the antimicrobial effect of
adding the second beta lactam is unpredictable and can sometimes
be antagonistic to the first
•continue administering oral azithromycin during the acute exacerbation
if it is a component of the chronic pulmonary regimen.
Simon RH. Cystic fibrosis: Antibiotic therapy for lung disease. UpToDate
http://www.uptodate.com/contents/cystic-fibrosis-antibiotic-therapy-for-lungdisease?source=search_result&search=cystic+fibrosis+and+pneumonia&selectedTitle=1%7E150
Page 33
xxx00.#####.ppt 7/16/2015 6:30:58 PM
Simon RH. Cystic fibrosis: Antibiotic therapy for lung disease.
UpToDate
Page
34
http://www.uptodate.com/contents/cystic-fibrosis-antibiotic-therapy-for-lungdisease?source=search_result&search=cystic+fibrosis+and+pneumonia&selectedTitle=1%7E150
xxx00.#####.ppt 7/16/2015 6:30:58 PM
Antibiotic synergy testing
• The only large clinical trial that studied the effect of
combination antibiotic susceptibility testing
‐failed to demonstrate any benefit associated with this
approach
• Meta analysis: Combination antibiotic susceptibility testing
‐did not improve clinical or bacteriologic outcomes
‐did not prolong the period until the next acute
exacerbation
Lancet. 2005;366(9484):463; Cochrane Database Syst Rev. 2008
Page
35
xxx00.#####.ppt 7/16/2015 6:30:59 PM
Categories of pneumonia
1. Community acquired pneumonia
2. Pneumonia in special populations
‐ immunocompromised
‐ cystic fibrosis
‐ chronically ventilator dependent
3. Ventilator associated pneumonia (VAP)
Page 36
xxx00.#####.ppt 7/16/2015 6:30:59 PM
Ventilator-dependent children
• tracheostomy tubes bypass the protection of the nose, mouth, and upper airway
• the tube may result in various degrees of ulceration and tracheal denudation
• a humidified circuit results in colonization of the trachea
‐ aspirates show an average of six isolates per specimen, and the mean bacterial
concentration was 107 organisms / ml
• In 1976:
‐ most frequent aerobic isolates - S. pneumoniae and S. aureus.
‐ predominant anaerobes - gram-positive cocci, F. nucleatum, and B. fragilis.
‐ replacement of one pathogen by another occurs frequently
• In 2010:
‐ gram-negative rods accounted for 71% of microorganisms
Ann Otol Rhinol Laryngol, 74 (1965), pp. 785–798; Chest, 85 (1984), pp. 39–44;Page
Chest,3776 (1979), pp. 420–
424 ; Chest, 74 (1978), pp. 635–639
xxx00.#####.ppt 7/16/2015 6:30:59 PM
Ventilator-dependent children
• Tracheitis v tracheobronchitis v pneumonia?
‐ colonization v real infection?
‐ culture material via tracheal aspirate suction trap, BAL, blind
protected telescoping catheter (miniBAL)?
‐ quantitative cultures, semi-quantitative?
•No correlation found between the concentrations of
polymorphonuclear leukocytes and quantitative bacterial counts
Chest, 74 (1978), pp. 635–639; CHEST 1979: 76: 420-424; CHEST 2013; 144(1):32–38; Pediatr Pulmonol. 2012;
Page 38
47:409–414; Ped Crit Care Med. 2008 Jan;9(1):96-100;
xxx00.#####.ppt 7/16/2015 6:31:00 PM
Ventilator-dependent children
• following trach placement 40% readmitted within 12 months
‐ 45% pneumonia / tracheitis
•clinical indicators
‐ oxygen saturations declined
‐ secretions changed in color, viscosity, or odor
‐ Increased need for airway suctioning
‐ Increased need for oxygen supplementation or ventilatory support
‐ new infiltrates or opacities on chest radiographs
•evidence-based guidelines lacking
‐ treat based on prior cultures or current gram stain
Chest, 74 (1978), pp. 635–639; CHEST 1979: 76: 420-424; CHEST 2013; 144(1):32–38; Pediatr Pulmonol. 2012;
Page 39
47:409–414; Ped Crit Care Med. 2008 Jan;9(1):96-100; Semin Pediatr Infect Dis 2006:17:11.
xxx00.#####.ppt 7/16/2015 6:31:00 PM
Categories of pneumonia
1. Community acquired pneumonia
2. Pneumonia in special populations
‐ immunocompromised
‐ cystic fibrosis
‐ chronically ventilator dependent
3. Ventilator associated pneumonia (VAP)
Page 40
xxx00.#####.ppt 7/16/2015 6:31:00 PM
Ventilator Associated Pneumonia (VAP)
• The second most common hospital associated infection
• Accounts for 20% nosocomial infections in PICU’s
• Increased morbidity for patients
• Increased length of stay in the hospital
• Increased cost
•trach /vent dependent kids sig more likely to develop a VAT
CHEST 2013; 144(1):32–38
Page 41
xxx00.#####.ppt 7/16/2015 6:31:01 PM
VAP
• clinical criteria for VAP are subjective and nonspecific:
‐ worsening oxygenation
‐ change in the quality or quantity of sputum production
‐ new or progressive infiltrates
• from our AQI project - On 4 consecutive days, 4 different radiologists
read the films and used 4 different words/phrases to describe the
same thing
• autopsy series reveal that 1/3 to ½ of patients who met clinical criteria
for VAP did not have pneumonia.
• CDC working group - shift the focus of surveillance from pneumonia alone to
complications of mechanical ventilation in general.
The Joint Commission Journal on Quality and Patient Safety 2008: 34(11) 629.
Page 42
xxx00.#####.ppt 7/16/2015 6:31:01 PM
NEJM 2013:368;16
Page 43
xxx00.#####.ppt 7/16/2015 6:31:01 PM
VAC – new definitions
• do not include radiographic criteria
‐ reflects the recognition that they are counterproductive in surveillance definitions
‐ because they introduce substantial complexity and subjectivity without increasing
accuracy
• opportunity to identify a population of patients who have serious complications that have
previously not been acknowledged or attended to by quality-improvement programs
• will enable hospitals to benchmark their rates against peer institutions in a more
meaningful way
• Antibiotic stewardship - the inclusion of an antibiotic criterion in the definition of IVAC will
provide hospitals with a routine, widely reportable benchmark for the prescribing of
antibiotics in their ICUs
Page 44
xxx00.#####.ppt 7/16/2015 6:31:02 PM
VAC in pediatrics
• Of 645 mechanically ventilated patients admitted, 22 (3.4%) met criteria for VAC
- incidence 0.829%, lower than the 2.3% to 11.5% reported in adult studies
• Patients with VAC experienced ‐ a significantly longer mean length of stay in the PICU (27.6 22.043 days vs 6.61
7.27 days; P 5 .000)
‐ and higher mean total ventilator time (519.31 457.60 h vs 95.60 138.83 h; P 5
.000).
• significant association between tracheostomy and VAC ( P < .000) and between
chronic ventilator dependence and VAC ( P < .002).
• cultured microorganisms: Gram-negative rods 71%; staphylococcal or streptococcal
species 26%
‐ Of those with two or more potentially causative pathogens - 67% (n=4) were in
patients with a tracheostomy
CHEST 2013; 144(1):32–38
Page 45
xxx00.#####.ppt 7/16/2015 6:31:02 PM
Prevention
• bundled care!
Page 46
xxx00.#####.ppt 7/16/2015 6:31:06 PM
Page 47
xxx00.#####.ppt 7/16/2015 6:31:06 PM
Page 48
xxx00.#####.ppt 7/16/2015 6:31:06 PM
Page 49
xxx00.#####.ppt 7/16/2015 6:31:07 PM
References:
• Virkki R, Juven T, Rikalainen H, Svedström E, Mertsola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax.
2002;57(5):438.
• Tan TQ, Mason EO Jr, Barson WJ, Wald ER, Schutze GE, Bradley JS, Arditi M, Givner LB, Yogev R, Kim KS, Kaplan SL. Clinical characteristics
and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.
Pediatrics. 1998;102(6):1369.
• Finnegan OC, Fowles SJ, White RJ. Radiographic appearances of mycoplasma pneumonia. Thorax. 1981;36(6):469.
• Korppi M, Kiekara O, Heiskanen-Kosma T, Soimakallio S. Comparison of radiological findings and microbial aetiology of childhood pneumonia.
Acta Paediatr. 1993;82(4):360.
• Simpson W, Hacking PM, Court SD, Gardner PS. The radiological findings in respiratory syncytial virus infection in children. II. The correlation of
radiological categories with clinical and virological findings. Pediatr Radiol. 1974;2(3):155.
• Dawson KP, Long A, Kennedy J, Mogridge N. The chest radiograph in acute bronchiolitis. J Paediatr Child Health. 1990;26(4):209.
• Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med.
1999;33(2):166.
• Margolis P, Gadomski A. The rational clinical examination. Does this infant have pneumonia? JAMA. 1998;279(4):308.
• Klompas M. Complications of Mechanical Ventilation — The CDC’s New Surveillance Paradigm. NEJM 2013:368;16
• Meyers, J., Shook, J., Pella, J., & Cron, S. G. Complete respiratory assessment score accurately predicts outcomes in children with acute
reactive airway disease exacerbations [Abstract]. Academic Emergency Medicine, 1996: 3(5), 396.
• Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey
BW. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol. 2001;32(5):356.
Page 50
xxx00.#####.ppt 7/16/2015 6:31:07 PM
References cont
• Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in
young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91.
• Speert DP. Advances in Burkholderia cepacia complex. Paediatr Respir Rev. 2002;3(3):230.
• Fauroux B, Hart N, Belfar S, BouléM, Tillous-Borde I, Bonnet D, Bingen E, Clément A. Burkholderia cepacia is associated with pulmonary
hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol. 2004;42(12):5537.
• Kalish LA, Waltz DA, Dovey M, Potter-Bynoe G, McAdam AJ, Lipuma JJ, Gerard C, Goldmann D. Impact of Burkholderia dolosa on lung function
and survival in cystic fibrosis. Am J Respir Crit Care Med. 2006;173(4):421.
• Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B. Defining a pulmonary exacerbation in cystic fibrosis.
J Pediatr. 2001;139(3):359.
• Aaron SD, Vandemheen KL, Ferris W, Fergusson D, Tullis E, Haase D, Berthiaume Y, Brown N, Wilcox P, Yozghatlian V, Bye P, Bell S, Chan F,
Rose B, Jeanneret A, Stephenson A, Noseworthy M, Freitag A, Paterson N, Doucette S, Harbour C, Ruel M, MacDonald N. Combination
antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind,
controlled clinical trial. Lancet. 2005;366(9484):463.
• Waters V, Ratjen F. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in
cystic fibrosis. Cochrane Database Syst Rev. 2008
• Simon RH. Cystic fibrosis: Antibiotic therapy for lung disease. UpToDate (found at: http://www.uptodate.com/contents/cystic-fibrosis-antibiotictherapy-for-lung-disease?source=search_result&search=cystic+fibrosis+and+pneumonia&selectedTitle=1%7E150)
• Saiman L, Siegel J, Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for
patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J
Infect Control. 2003;31(3 Suppl):S1.
Page 51
xxx00.#####.ppt 7/16/2015 6:31:08 PM
References con’t
• Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell
PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr.
2009;155(6 Suppl):S73.
• Brook I. Bacterial Colonization, Tracheobronchitis, and Pneumonia following Tracheostomy and Long-Term Intubation in Pediatric Patients.
CHEST 1979: 76: 420-424
• Simpson VS, Bailey A, Higgerson RA and Christie L M. Ventilator-Associated Tracheobronchitis in a Mixed Medical/Surgical Pediatric ICU.
CHEST 2013; 144(1):32–38
• Nseir S, Di Pompeo C, Soubrier S, et al . Effect of ventilatorassociated tracheobronchitis on outcome in patients without chronic respiratory
failure: a case-control study . Crit Care 2005 ; 9 ( 3 ): R238 - R245 .
• Agrafi otis M Siempos II, Falagas ME . Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic
review and meta-analysis . Respir Med . 2010 ; 104 ( 3 ): 325 - 336 .
• Dallas J, Skrupky L, Abebe N, Boyle WA III, Kollef MH . Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population .
Chest . 2011 ; 139 ( 3 ): 513 - 518 .
• Kun SS, Edwards JD, Davidson Ward SL, Keens TG. Hospital Readmissions for Newly Discharged Pediatric Home Mechanical Ventilation
Patients. Pediatr Pulmonol. 2012; 47:409–414.
• Graf JM, Montagnino BA, Hueckel R, McPherson ML. Pediatric tracheostomies: a recent experience from one academic center. Ped Crit Care
Med. 2008 Jan;9(1):96-100.
• Fishman JA. Pulmonary infections in immunocompromised patients. Found at: http://www.uptodate.com/contents/pulmonary-infections-inimmunocompromised-patients?source=search_result&search=pneumonia+in+immunocompromised&selectedTitle=2%7E150
• Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741.
Page 52
xxx00.#####.ppt 7/16/2015 6:31:09 PM
• Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., et al.. The management of communityacquired pneumonia in
infants and children older than 3 months of age: Clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious
Diseases Society of America. Clinical Infectious Diseases 2011: 53(7), e25-e76.
• Michelow, I. C., Olsen, K., Lozano, J., Rollins, N. K., Duffy, L. B., Ziegler, T., et al. (2004). Epidemiology and clinical characteristics of
communityacquired pneumonia in hospitalized children. Pediatrics, 2004:113(4), 701-707.
• S.A. Friedberg, T.E. Griffith, G.M. Hass. Histologic changes in the trachea following tracheostomy. Ann Otol Rhinol Laryngol, 74 (1965), pp. 785–
798
• M.S. Niederman, R.D. Ferranti, A. Zeigler et al. Respiratory infection complicating long term tracheostomy. The implication of persistent gramnegative tracheobronchial colonization. Chest, 85 (1984), pp. 39–44
• J.G. Barlett, L.G. Faling, S. Willey. Quantitative Tracheal bacteriologic and cytologic studies in patients with long term tracheostomies. Chest, 74
(1978), pp. 635–639
• Graf J, Stein F. Tracheitis in pediatric patients. Semin Pediatr Infect Dis 2006:17:11.
• Brilli RJ, Sparling KW, Lake MR, Butcher J, Myers, SS, Clark MD, Helpling A, Stutler ME.The Business Case for Preventing Ventilator-Associated
Pneumonia in Pediatric Intensive Care Unit Patients. The Joint Commission Journal on Quality and Patient Safety 2008: 34(11) 629.
Page 53
xxx00.#####.ppt 7/16/2015 6:31:11 PM